Geron(GERN) - 2024 Q4 - Annual Results

Our mission is to change lives by changing the course of blood cancer January 2025 Forward-Looking Statements Except for the historical information contained herein, this presentation contains forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements, include, without limitation, those regarding: (i) the Company's belief that RYTELO is a highly differentiated treatment with blockbuster potent ...